Tricares Successfully Closes Series C Financing, Raising €51M To Fund Further Development And Clinical Trials Of Minimally Invasive Treatment For Tricuspid Regurgitation
Dec 06, 2022•over 2 years ago
Amount Raised
€51 Million
Round Type
series c
Description
TRiCares Successfully Closes Series C Financing, Raising €51m to Fund Further Development and Clinical Trials of Minimally Invasive Treatment for Tricuspid Regurgitation
FundzWatch™ Score
62
Medium Activity
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech